Legend Biotech Corp Stock Alpha and Beta Analysis
| LEGN Stock | USD 40.42 0.67 1.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Legend Biotech Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Legend Biotech over a specified time horizon. Remember, high Legend Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Legend Biotech's market risk premium analysis include:
Beta 0.54 | Alpha (0.54) | Risk 3.16 | Sharpe Ratio (0.16) | Expected Return (0.50) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Legend |
Legend Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Legend Biotech market risk premium is the additional return an investor will receive from holding Legend Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Legend Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Legend Biotech's performance over market.| α | -0.54 | β | 0.54 |
Legend Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Legend Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Legend Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Legend Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Legend Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Legend Biotech shares will generate the highest return on investment. By understating and applying Legend Biotech stock market price indicators, traders can identify Legend Biotech position entry and exit signals to maximize returns.
Legend Biotech Return and Market Media
The median price of Legend Biotech for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 47.79 with a coefficient of variation of 11.78. The daily time series for the period is distributed with a sample standard deviation of 5.58, arithmetic mean of 47.41, and mean deviation of 4.58. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | CARVYKTI is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as ... | 09/27/2024 |
2 | Krane Funds Advisors LLC Has 915,000 Holdings in Legend Biotech Co. | 10/22/2024 |
3 | Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results | 10/24/2024 |
4 | Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma | 11/05/2024 |
5 | Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights | 11/12/2024 |
6 | Legend Biotech Corp Q3 2024 Earnings Call Highlights CARVYKTIs Impressive Growth Amid ... | 11/13/2024 |
7 | Legend Biotechs SWOT analysis stock shows promise amid CAR-T therapy growth | 11/14/2024 |
8 | Legend Biotech Posts Quarterly Earnings Results, Beats Expectations By 0.22 EPS | 11/15/2024 |
9 | Why Is Legend Biotech Corporation Among the Worst Performing Biotech Stocks in 2024 | 11/21/2024 |
About Legend Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Legend or other stocks. Alpha measures the amount that position in Legend Biotech Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 14.37 | 17.19 | 21.69 | 22.78 | Receivables Turnover | 1.78 | 2.57 | 1.82 | 1.06 |
Legend Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Legend Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Legend Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Legend Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Legend Biotech. Please utilize our Beneish M Score to check the likelihood of Legend Biotech's management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 16th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Legend Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Legend Biotech Backtesting, Legend Biotech Valuation, Legend Biotech Correlation, Legend Biotech Hype Analysis, Legend Biotech Volatility, Legend Biotech History and analyze Legend Biotech Performance. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Legend Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.